Avecho Biotechnology Limited is a biopharmaceutical company focused on the development and commercialisation of innovative therapies originating from its proprietary technology platform. Its operations involve the research, development and commercialisation of treatments for various cancers and other serious diseases. Its objectives are to develop and commercialise novel therapies that provide significant clinical benefit to patients, whilst creating value for shareholders.